本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Akero Therapeutics

46.73
-0.2100-0.45%
盘后46.900.1700+0.36%18:18 EDT
成交量:49.76万
成交额:2,313.09万
市值:37.38亿
市盈率:-12.36
高:47.34
开:47.01
低:46.02
收:46.94
52周最高:58.40
52周最低:21.34
股本:7,998.90万
流通股本:6,777.24万
量比:0.79
换手率:0.73%
股息:- -
股息率:- -
每股收益(TTM):-3.7801
每股收益(LYR):-3.7544
净资产收益率:-31.14%
总资产收益率:-20.36%
市净率:3.64
市盈率(LYR):-12.45

数据加载中...

2025/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

重要事件披露

Form 8-K - Current report
2025/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/04

重要事件披露

Form 8-K - Current report
2025/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/12

重要事件披露

Form 8-K - Current report
2025/05/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/28

重要事件披露

Form 8-K - Current report
2025/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/30

重要事件披露

Form 8-K - Current report
2025/01/28

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities